Arginine-rhamnosylation as new strategy to activate translation elongation factor P

Jürgen Lassak, Eva C. Keilhauer, Maximilian Fürst, Kristin Wuichet, Julia Gödeke, Agata L. Starosta, Jhong Min Chen, Lotte Søgaard-Andersen, Jürgen Rohr, Daniel N. Wilson, Susanne Häussler, Matthias Mann, Kirsten Jung

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Abstract

Ribosome stalling at polyproline stretches is common and fundamental. In bacteria, translation elongation factor P (EF-P) rescues such stalled ribosomes, but only when it is post-translationally activated. In Escherichia coli, activation of EF-P is achieved by (R)-Î 2-lysinylation and hydroxylation of a conserved lysine. Here we have unveiled a markedly different modification strategy in which a conserved arginine of EF-P is rhamnosylated by a glycosyltransferase (EarP) using dTDP-L-rhamnose as a substrate. This is to our knowledge the first report of N-linked protein glycosylation on arginine in bacteria and the first example in which a glycosylated side chain of a translation elongation factor is essential for function. Arginine-rhamnosylation of EF-P also occurs in clinically relevant bacteria such as Pseudomonas aeruginosa. We demonstrate that the modification is needed to develop pathogenicity, making EarP and dTDP-L-rhamnose-biosynthesizing enzymes ideal targets for antibiotic development.

Original languageEnglish
Pages (from-to)266-270
Number of pages5
JournalNature Chemical Biology
Volume11
Issue number4
DOIs
StatePublished - Apr 1 2015

Bibliographical note

Publisher Copyright:
© 2015 Nature America, Inc. All rights reserved.

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Arginine-rhamnosylation as new strategy to activate translation elongation factor P'. Together they form a unique fingerprint.

Cite this